Abstract
We have analysed 236 Norwegian phenylketonuria (PKU) alleles by a combination of mutation scanning methods, restriction enzyme-based assays and DNA sequencing. Thirty-three different mutations constituted 99.6% of all mutant alleles (only 1 allele remains unidentified), 23 of these have been identified also in other European countries. Twenty were predicted missense mutations, 6 splice mutations, 4 nonsense mutations and 2 deletion mutations and 1 mutation disrupted the start codon. The 8 most common mutations represented 83.5% of the PKU alleles, with single allele frequencies ranging from 5.9 to 15.7%. Four of these mutations (R261Q, R408W, Y414C, and IVS12ntl) are commonly occurring also in PKU patients in other European countries, while the other 4 (G46S, G272X, F299C, and R408Q) have higher frequencies in Norway than in any other country studied. Six mutations (I65T, L249F, P281L, Y356X, R158Q, and R252W) have frequencies between 0.8% and 2.1%, and 19 mutations were encountered only once. The majority of PKU mutations were found on the same RFLP/VNTR haplotype backgrounds in Norway as in other European populations, suggesting that only a few of the mutations may represent recurrent mutations (<3.4%). Among 10 mutations only reported for our population, we detected 2 de novo mutations (0.8%) arisen in Norway. From the birthplaces of the probands’ grandparents, each mutation seemed to have an individual geographic distribution within Norway, with patterns of local mutation clustering. Our observations are compatible with multiple founder effects and genetic drift for the distribution of PKU mutations within Norway.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Scriver CR, John SMW, Rozen R, Eisensmith RC, Woo SLC: Association between populations, phenylketonuria mutations and RFLP haplotypes at the phenylalanine hydroxylase locus: An overview. Dev Brain Dysfunct 1993;6:11–25
Woo SLC: Collation of RFLP haplotypes at the human phenylalanine hydroxylase (PAH) locus. Am J Hum Genet 1988;43:781–783
Chakraborty R, Lidsky AS, Daiger SP, Güttier F, Sullivan S, DiLella AG, Woo SLC: Polymorphic DNA haplotypes at the human phenylalanine hydroxylase locus and their relationship with phenylketonuria. Hum Genet 1987;76:40–46
Eisensmith RC, Okano Y, Dasovich M, Wang T, Güttier F, Lou H, Guldberg P, Lichter-Kon-ecki U, Konecki DS, Svensson E, Hagenfeldt L, Rey F, Munnich A, Lyonnet S, Cockburn F, Connor JM, Pembrey ME, Smith I, Gitzelmann R, Steinmann B, Apold J, Eiken HG, Giovanmni M, Riva E, Longhi R, Romano C, Cerone R, Naughten ER, Mullins C, Cahalane S, Özalp I, Fekete G, Schuler D, Berencsi Y, Nasz I, Brdicka R, Kamaryt J, Pijackova A, Cabalska B, Boszkowa K, Schwartz E, Kalinin VN, Jin L, Chackraborty R, Woo SCL: Multiple origins of phenylketonuria in Europe Am J Hum Genet 1992;51:1355–1365.
Gedde-Dahl T: Population structure in Norway. Inbreeding, distance and kinship. Hereditas 1973;73:211–232
Saugstad LF: Anthropological significance of phenylketonuria. Clin Genet 1975;7:52–61
Treacy E, Byck S, Clow C, Scriver CR: ‘Celtic’ phenylketonuria chromosomes found? Evidence in two regions of Quebec province. Eur J Hum Genet 1993;1:220–228
Eisensmith RC, Goltsov AA, O’Neill C, Tyfield L, Schwartz EI, Kuzmin AI, Baranovskaya SS, Tsukerman GL, Treacy E, Scriver CR, Güttier F, Guldberg P, Eiken HG, Apold J, Svensson E, Naughten E, Cahalane SF, Croke DT, Cockburn F, Woo SLC: Recurrence of the R408W mutation in the PAH locus in Europeans. Am J Hum Genet 1995;56:278–286
Apold J, Eiken HG, Odland E, Fredriksen Å, Bakken A, Lorens JB, Boman H: A termination mutation prevalent in Norwegian haplotype 7 phenylketonuria genes. Am J Hum Genet 1990;47:1002–1007
Apold J, Eiken HG, Svensson E, Kunert E, Kozak L, Cechak P, Güttier F, Giltay J, Lichter-Konecki U, Melle D, Jaruzelska JM: The phenylketonuria G272X haplotype 7 mutation in European populations. Hum Genet 1993,92: 107–109.
Eiken HG, Stangeland K, Skjelkvåle L, Knappskog PM, Boman H, Apold J: PKU mutations R408Q and F299C in Norway: Haplotype associations, geographic distributions and phenotype characteristics. Hum Genet 1992;88:608–612
Eiken HG, Knappskog PM, Apold J, Fiatmark T: PKU mutation G46S is associated with increased aggregation and degradation of the phenylalanine hydroxylase enzyme. Hum Mut 1996;7:228–238
Eiken HG, Knappskog PM, Apold J, Skjelkvåle L, Boman H: A de novo phenylketonuria mutation: ATG(Met) to ATA(Ile) in the start codon of the phenylalanine hydroxylase gene. Hum Mut 1992;1:388–391
Knappskog PM, Eiken HG, Martinez A, Bruland O, Apold J, Fiatmark T: A PKU mutation (D143G) associated with an apparent high residual enzyme activity: Expression of a kinetic variant form of phenylalanine hydroxylase in three different systems. Hum Mut, in press.
Ellingsen S. Knappskog PM, Eiken HG: Phenylketonuria splice mutation (EXON6nt-96A>g) masquerading as missense mutation (Y204C). Hum Mut, in press.
Eiken HG, Knappskog PM, Guldberg P, Apold J: DGGE analysis as a supplement to SSCP analysis of the phenylalanine hydroxylase gene: Detection of eight (one de novo and seven inherited) of nine remaining Norwegian PKU mutations. Hum Mut, m press.
Pettersen RD, Saugstad OD, Heyerdahl S, Motzfeldt K, Lie SO: Screening av nyfødte l Norge for alvorlig metabolsk sykdom. Tidsskr Nor Lægeforen 1995;115:584–587
Dwomiczak B, Wedemeyer N, Eigel A, Horst J: PCR detection of the PvuII (Ee) RFLP at the human phenylalanine hydroxylase (PAH) locus. Nucleic Acids Res 1991; 19:1958.
Dwomiczak B, Wedemeyer N, Horst J: PCR detection of the BglII RFLP at the human phenylalanine hydroxylase (PAH) locus. Nucleic Acids Res 1991; 19:1958.
Wedemeyer N, Dwomiczak B, Horst J: PCR detection of the MspI (Aa) RFLP at the human phenylalanine hydroxylase (PAH) locus. Nucleic Acids Res 1991;19:1959.
Goltsov AA, Eisensmith RC, Woo SLC: Detection of the XmnI RFLP at the human phenylalanine hydroxylase locus by PCR. Nucleic Acids Res 1991;20:927.
Goltsov AA, Eisensmith RC, Konecki DS, Lichter-Konecki U, Woo SLC: Association between mutations and a VNTR in the human phenylalanine hydroxylase gene. Am J Hum Genet 1992;51:627–636
Orita M, Suzuki Y, Sekiya T, Hayashi K: Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989;5:874–879
Guldberg P, Henriksen KF, Güttier F: Molecular analysis of phenylketonuria in Denmark: 99% of the mutations detected by denaturing gradient gel electrophoresis. Genomics 1993;17:141–146
Wang T, Okano Y, Eisensmith R, Huang SZ, Zeng YT, Lo WHY, Woo SLC: Molecular genetics of phenylketonuria in Orientals: Linkage disequilibrium between a termination mutation and haplotype 4 of the phenylalanine hydroxylase gene. Am J Hum Genet 1989;45:675–680
Okano Y, Wang T, Eisensmith RC, Steinmann B, Gitzelmann R, Woo SLC: Missense mutations associated with RFLP haplotypes 1 and 4 of the human phenylalanine hydroxylase gene. Am J Hum Genet 1990;46:18–25
Wang T, Okano Y, Eisensmith RC, Lo WHY, Huang SZ, Zeng YT, Yuan SR, Woo SLC: Missense mutations prevalent in Orientals with phenylketonuria: Molecular characterization and clinical implications. Genomics 1991;10: 449–456.
Wang T, Okano Y, Eisensmith RC, Lo WHY, Huang SZ, Zeng YT, Yuan LF, Liu SR, Woo SLC: Identification of three novel PKU mutations among Chinese: Evidence for recombination or recurrent mutation at the PAH locus. Genomics 1992;13:230–231
DiLella AG, Huang WM, Woo SLC: Screening for phenylketonuria mutations by DNA amplification with the polymerase chain reaction. Lancet 1988;i:497–499
Eiken HG, Odland E, Boman H, Skjelkvåle L, Engebretsen LF, Apold J: Application of natural and amplification created restriction sites for the diagnosis of PKU mutations. Nucleic Acids Res 1991;7:1427–1430
Eiken HG, Knappskog PM, Apold J: Restriction enzyme-based assays for complete genotyping of phenylketonuria patients. Dev Brain Dysfunct 1993;6:53–59
Reinskou T: Distribution of the Gc types in Norway. Acta Genet Med Gemellol (Roma) 1965;15:33–44
PAH Mutation Analysis Consortium, July 1995 (PAH Mutation database: http://www.mcgill.ca/pahdburl).
Byck S, Morgan K, Tyfield L, Dwomiczak B, Scriver CR: Evidence for origin by recurrent mutation of the phenylalanine hydroxylase R408W mutation on two haplotypes in European and Quebec populations. Hum Mol Genet 1994;3:1675–1677
Cooper D, Youssoufian H: The CpG dinucleotide and human genetic disease. Hum Genet 1988;78:151–155
Knappskog PM, Eiken HG, Martínez A, Flatmark T, Apold J: The PKU mutation S349P causes complete loss of catalytic activity in the recombinant phenylalanine hydroxylase enzyme. Hum Genet 1994;95:171–173
Chou Q, Russel M, Birch D, Raymond J, Bloch W: Prevention of pre-PCR mis-priming and primer dimerization improves low-copy-number amplifications. Nucleic Acids Res 1992;20:1717–1723
Svensson E, von Döbeln U, Eisensmith RC, Hagenfeldt L, Woo SLC: Relation between genotype and phenotype in Swedish phenylketonuria and hyperphenylalaninemia patients. Eur JPediatr 1993;152:132–139
Zschocke J, Graham CA, Stewart FJ, Carson DJ, Nevin NC: Automated sequencing detects all mutations in Northern Irish patients with phenylketonuria and mild hyperphenylalaninemia. Acta Pediatr Scand Suppl 1994;407:37–38
Acknowledgements
We thank Savio L.C. Woo for sharing PAH intron sequence with us prior to publication. The skilful technical assistance of Jorunn Bringsli and Olaug F. Bratbak, and the continued cooperation of PKU families in Norway are gratefully acknowledged.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Eiken, H.G., Knappskog, P.M., Boman, H. et al. Relative Frequency, Heterogeneity and Geographic Clustering of PKU Mutations in Norway. Eur J Hum Genet 4, 205–213 (1996). https://doi.org/10.1159/000472200
Received:
Revised:
Accepted:
Issue date:
DOI: https://doi.org/10.1159/000472200
Key Words
This article is cited by
-
Prevalence of tetrahydrobiopterine (BH4)‐responsive alleles among Austrian patients with PAH deficiency: comprehensive results from molecular analysis in 147 patients
Journal of Inherited Metabolic Disease (2013)
-
The mutation spectrum of hyperphenylalaninaemia in the Republic of Ireland: the population history of the Irish revisited
European Journal of Human Genetics (2002)
-
Phenylketonuria genotypes correlated to metabolic phenotype groups in Norway
European Journal of Pediatrics (1996)
